Cite
HARVARD Citation
Verma, P. et al. (2021). IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival. Journal of pediatric hematology/oncology. 43 (4), pp. e466-e471. [Online].